Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis

Abstract Background Biological therapies have improved the clinical course and quality of life of rheumatoid arthritis (RA) patients. Despite the availability and effectiveness of these treatments, some patients experience multiple failures to biologic disease-modifying antirheumatic drugs (bDMARDs)...

Full description

Bibliographic Details
Main Authors: Marta Novella-Navarro, Chamaida Plasencia, Carolina Tornero, Victoria Navarro-Compán, José L. Cabrera-Alarcón, Diana Peiteado-López, Laura Nuño, Irene Monjo-Henry, Karen Franco-Gómez, Alejandro Villalba, Alejandro Balsa
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Biological therapy
Refractory disease
Online Access:https://doi.org/10.1186/s13075-020-02354-1

Internet

https://doi.org/10.1186/s13075-020-02354-1

Similar Items